Loading clinical trials...
Loading clinical trials...
Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of MOA-728 Administered Orally to Healthy Subjects
Conditions
Interventions
MOA-728
Locations
1
United States
Philadelphia, Pennsylvania, United States
Start Date
March 1, 2006
Completion Date
August 1, 2006
Last Updated
November 25, 2019
NCT06430957
NCT07462481
NCT07411612
NCT07408037
NCT07349719
NCT07344402
Lead Sponsor
Bausch Health Americas, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions